BridgeMD
New treatment option for Arthritis Knee
Official title Developing an Opioid Taper Intervention Before Total Joint Arthroplasty
ClinicalTrials.gov ID: NCT05788016
What this study is testing
- What it's testing
- The goal of this clinical trial is to develop an pharmacist-led preoperative opioid taper intervention for patients undergoing total knee or hip replacement who are on chronic opioids before their surgery. The main questions it aims to answer are: Is the intervention feasible and acceptable to patients?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- decided to pursue primary, unilateral total knee or hip arthroplasty with planned surgery date in 4-8 weeks
- currently taking between 20 and 90 MME of oral opioids, and that dose has been stable for at least 3 months
- have a reliable telephone number for contact
- speaks English
You likely can't join if
- Taking opioid medications that include:
- Buprenorphine
- Methadone
- Long-acting formulations of opioid pain medications (e.g., extended-release oxycodone and extended-release morphine)
- Transdermal formations of opioid pain medications (e.g., fentanyl patches)
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.